Ascendis Pharma A/S - Ordinary Shares (ASND)

CUSIP: K08588103

Q3 2026 13F Holders as of 30 Sep 2026

Holder snapshot 6 signals
Share change
+43,565
SEC-reported price per share
$227.83
Number of holders
42
Value change
+$9,718,513
Number of buys
34
Number of sells
9
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
62,714,857

Security key

K08588103

Report period

Q3 2026

Institutions

42

Top holders

10

Ownership snapshot

Top reported holders of ASND - Ascendis Pharma A/S - Ordinary Shares (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
T. Rowe Price Investment ...
Disclosed value leader
RA CAPITAL MANAGEMENT, L.P.
Comparable rows
6/15
Latest evidence
30 Jun 2026
13F 13D/G Lead comparable stake: 10% 9 rows are not safely comparable across share classes. 13D/G row: T. Rowe Price Investment Management, Inc. Showing 1-6 of 15 holder rows.

Quick read

T. Rowe Price Investment Management, Inc. leads the comparable SEC ownership view at 10%.

6 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens T. Rowe Price Investment Management, Inc.'s linked filing trail.
Comparable ownership Top 5
T. Rowe Price Investment Manageme... 10%
WESTFIELD CAPITAL MANAGEMENT CO LP 8.5%
FMR LLC 6.6%
Janus Henderson Group Ltd. 6%
Artisan Partners Limited Partnership 4.2%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
T. Rowe Price Investment Management, Inc.
13F 13D/G
Company
10%
Reported 13D/G · 30 Apr 2026
$1,801,653,000
6,754,846 shares
— 30 Jun 2026
WESTFIELD CAPITAL MANAGEMENT CO LP
13F 13D/G
Company · Westfield Capital Management Company, L.P.
8.5%
Reported 13D/G · 31 Dec 2025
$1,279,793,795
4,798,267 shares
— 30 Jun 2026
FMR LLC
13D/G 13F
Company
6.6%
Reported 13D/G · 31 Mar 2026
$957,439,699
3,852,101 shares
-$197,557,979 31 Mar 2026
Janus Henderson Group Ltd.
13D/G
JANUS HENDERSON GROUP PLC
6%
Reported 13D/G · 31 Mar 2026
$924,469,795
3,719,452 shares
-$150,026,520 31 Mar 2026
Artisan Partners Limited Partnership
13F 13D/G
Company · Artisan Partners Asset Management Inc.
4.2%
Reported 13D/G · 30 Jun 2026
$702,546,942
2,634,024 shares
— 30 Jun 2026
Capital International Investors
13F 13D/G
Company
3.2%
Reported 13D/G · 31 Mar 2026
$530,403,126
1,988,614 shares
— 30 Jun 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
42
Shares
377,825
Rows available
42
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2026 vs Q2 2026 Across Filers

Q2 2026 holders
304
Q3 2026 holders
42
Holder diff
-262
Investor Q2 2026 Shares Q3 2026 Shares Share Diff Share Chg % Q2 2026 value Q3 2026 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .